Biggest News Aggregation in the World
📰 Patrick Lin News

Page 5 - Patrick Lin News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patrick Lin. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Processa Pharmaceuticals to Host Conference Call to Discuss First Quarter 2022 Results and Provide Drug Development Update on May 12, 2022 at 4: 30 p.m. EST

05.05.2022 - HANOVER, MD, May 05, 2022 (GLOBE NEWSWIRE) - Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need ...
Patrick Lin Michael Floyd Pharmaceuticals Inc Processa Pharmaceuticals More Information Processa Pharmaceuticals To Host Conference Call Discuss First Quarter 2022 Results And Provide Drug Development Update On May 12

Processa Pharmaceuticals (NASDAQ:PCSA) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) from a sell rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who […]
United States Thomson Reuter Patrick Lin David Young Heatwurx Inc Geode Capital Management

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Expected to Post Earnings of -$0.18 Per Share

Wall Street brokerages expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) to post earnings per share of ($0.18) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings of ($0.90) per share in the same quarter last year, which indicates a positive year-over-year […]
Patrick Lin David Young Processa Pharmaceuticals Inc Geode Capital Management Processa Pharmaceuticals Company Profile Get Rating Zacks Investment Research

Processa Pharmaceuticals (NASDAQ:PCSA) Rating Lowered to Sell at Zacks Investment Research

Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality […]
United States Patrick Lin David Young Heatwurx Inc Geode Capital Management Zacks Investment Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science